The second phase of GlaxoSmithKline's experimental Ebola vaccine trials have been slated to begin in February 2015 and will hold in Nigeria, Cameroon, Ghana, Mali and Senegal.
Vaccine trials to hold in Nigeria in February
The trials were expected to commence earlier but were postponed after national regulators expressed the need to gather more information.
Recommended articles
A two-day meeting of the national regulatory authorities and ethics committees was hosted earlier this week by the World Health Organization (WHO) after which the UN agency stated that all aspects of the proposed trials had been thoroughly discussed.
“Reviewing countries requested additional documentation from the manufacturer of the vaccine, GlaxoSmithKline, before authorization of the trials,” the WHO said in a statement.
“If these steps are completed to the satisfaction of the national authorities, Phase II trials are likely to begin in February,” the statement added.
ADVERTISEMENT
GSK’s vaccine is currently in the first phase of clinical trials and its suitability for use in humans is being tested in Switzerland, Britain, Mali and the United States.
JOIN OUR PULSE COMMUNITY!
ADVERTISEMENT
Eyewitness? Submit your stories now via social or:
Email: eyewitness@pulse.ng
Recommended articles
Let’s drill 200k boreholes across the country — Obi begs wealthy Nigerians
Ondo 2024: Ex-governor's brother emerges gubernatorial candidate
UK varsity rolls out tuition, travel-free scholarship for Nigerian students
President Biden signs law to potentially ban TikTok if not sold
Ex-Governor, Fayose's money laundering trial adjourned as court fails to sit
Travel alert: Panic as fire breaks out at Lagos Airport
NGO allocates $36.5m to Nigeria, 15 other countries to eradicate trachoma
Senator sacrifices chicken to rain god to ask for rainfall — people are mad at him
Telecom calls on FG to tackle pricing issues, balance consumers affordability
ADVERTISEMENT
